Radiation Oncology Webinar Series

Description: This webinar will cover physics/dosimetry considerations, current clinical applications, and future directions of simulation free radiation therapy (SFRT). International experts will provide an overview of the rationale for SFRT, techniques utilized globally, and the process involved with establishing a SFRT program.

Moderator: Emile Gogineni, DO
Speakers:
Aaron Bush, MD	Thomas Eade, MBBS	Melissa O'Neil, RT

Program Materials

Requirements:

1. Title of Activity: Radiation Oncology Webinar Series
2. Date of Activity: May 17, 2023 
3. Educational/Learning Objectives
   1. After completing this activity, the participant should be better able to:
      1. Explain the history and current state of emerging radiation oncology treatment technologies.
      2. Identify research opportunities and clinical trials currently available related to emerging radiation oncology treatment technologies.
      3. Review active utilization of emerging radiation oncology treatment technologies domestically and abroad.
      4. Discuss future directions of emerging radiation oncology treatment technologies and the potential implications.
4. Physician Accreditation Statement (must stand-alone)
   1. The American College of Radiology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
5. Physician Credit Designation (must stand-alone)
   1. The American College of Radiology designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6. Instructions to Receive Credit
   1. In order to successfully complete the activity, participants must complete an activity evaluation and claim credit commensurate with their participation in the activity.
7. Contact Information
   1. For information about the accreditation of this program, please contact the ACR at info@acr.org.
8. Disclosure of Relevant Financial Relationships
   The ACR Disclosure Policy: The American College of Radiology (ACR) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ACR are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by ACR in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ACR to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ACR.
   
   The following planners and managers have no relevant financial relationships to disclose:
   Aaron Bush, MD; Carlye Armstrong, CHCP; Emile Gogineni DO; Maya Grant; Theresa Rudolph, CAPM
   
   The planners and managers have the following identified relevant financial relationships: 
   Arya Amini, MD - Consulting Fee: AstraZeneca; Contracted Research: Genentech, Varian, ReleXion; Speakers’ Bureau: AstraZeneca, Takeda Pharmaceutical 
   
   The following faculty members have no relevant financial relationships to disclose:
   Aaron Bush, MD
   Thomas Eade, MBBS
   Melissa O’Neil, RT

Description: This webinar will cover the radiobiological background, current clinical applications, and future directions of oncologic theranostics. National experts will provide an overview of the rationale for the use of diagnostic and therapeutic radionuclides, published translational and clinical data in addition to ongoing trials, and the process involved with establishing a theranostics program.

Moderators

• Emile Gogineni, DO and Aaron Bush, MD

Program Materials

Requirements:

1. Title of Activity: Radiation Oncology Webinar Series
2. Date(s) of Activity: February 15, 2023
3. Educational/Learning Objectives
   1. After completing this activity, the participant should be better able to:
      1. Explain the history and current state of emerging radiation oncology treatment technologies.
      2. Identify research opportunities and clinical trials currently available related to emerging radiation oncology treatment technologies.
      3. Review active utilization of emerging radiation oncology treatment technologies domestically and abroad.
      4. Discuss future directions of emerging radiation oncology treatment technologies and the potential implications.
4. Physician Accreditation Statement (must stand-alone)
   1. The American College of Radiology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
5. Physician Credit Designation (must stand-alone)
   1. The American College of Radiology designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6. Instructions to Receive Credit
   1. In order to successfully complete the activity, participants must, complete an activity evaluation and claim credit commensurate with their participation in the activity.
7. Contact Information
   1. For information about the accreditation of this program, please contact the ACR at info@acr.org.
8. Disclosure of Relevant Financial Relationships
   The ACR Disclosure Policy: The American College of Radiology (ACR) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ACR are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by ACR in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ACR to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ACR.
   
   The following planners and managers have no relevant financial relationships to disclose:
   Aaron Bush, MD; Carlye Armstrong, CHCP; Emile Gogineni DO; Maya Grant; Theresa Rudolph, CAPM
   
   The planners and managers have the following identified relevant financial relationships:
   Arya Amini, MD - Consulting Fee: AstraZeneca; Contracted Research: Genentech, Varian, ReleXion; Speakers’ Bureau: AstraZeneca, Takeda Pharmaceutical
   
   The following reviewers have no relevant financial relationships to disclose:
   Carlye Armstrong, CHCP
   
   The following faculty members have no relevant financial relationships to disclose:
   Freddy E Escorcia, MD, PhD
   
   The faculty members (speakers, etc.) have the following identified relevant financial relationships:
   Ephraim E. Parents, MD, PhD – Consulting fee: Blue Earth Diagnostics

Description: This webinar will cover current clinical applications and future directions of definitive management for patients with oligometastatic disease. National experts will cover oligometastatic disease related topics such as ongoing clinical trials, current disease site specific recommendations, and case based considerations.

 

 

Description: This webinar will explore themes related to current clinical applications and future directions of artificial intelligence (AI) in radiation oncology. National experts will cover AI-related topics such as enhancements in treatment planning, improved workflow efficiency, machine learning, and future job market implications. 

Description: This webinar will explore themes related to the innovative topic of heavy ion radiotherapy (carbon, neon, silicon, etc). International experts will cover topics such as current basic research opportunities in the United States, ongoing clinical applications abroad, and future directions of heavy ion radiotherapy.

Description: In this webinar, a diverse panel of expert radiation oncologists and a 4th year medical student focus on raising awareness on the declining applicant numbers in the radiation oncology match.

Description: Panel discussion with the Center for Medicare and Medicaid Innovation Center (CMMI) radiation oncology alternative payment model (RO-APM) team lead and radiation oncology economics experts.

Moderator

• Aaron Bush, MD, Lead ACR Radiation Oncology Webinars

Panelist

• Join Luh, MD FACR
• Najeeb Mohideen, MD
• Marcie O’Reilly, CMMI

This webinar will focus on advocacy efforts in radiation oncology and how to leverage the resources of organized medicine groups such as the ACR to advocate for the best oncologic treatments for patients.

In this webinar, diverse panelists discusses job market concerns in radiation oncology in the context of the COVID-19 pandemic.

Description: This webinar will cover diversity, equity, and inclusion within the field of radiation oncology, focusing on interventions that can be employed to provide meaningful change. National experts will discuss aspects within education and training, patient care, and the workforce related to diversity, aiming to provide concrete examples of avenues to pursue in order to implement impactful changes in policy and structure. 

Moderator:
Emile Gogineni, DO	Curtiland Deville Jr., MD
Speakers:
Reshma Jagsi, MD, DPhil	Jerry Jaboin, MD, PhD	Rachel Jimenez, MD

Program Materials

Requirements:

1. Title of Activity: Radiation Oncology Webinar Series
2. Date of Activity: August 16, 2023
3. Educational/Learning Objectives
   1. After completing this activity, the participant should be better able to:
      i. Explain the history and current state of emerging radiation oncology treatment technologies.
      ii. Identify research opportunities and clinical trials currently available related to emerging radiation oncology treatment technologies.
      iii. Review active utilization of emerging radiation oncology treatment technologies domestically and abroad.
      iv. Discuss future directions of emerging radiation oncology treatment technologies and the potential implications.
      
       
4. Physician Accreditation Statement 
   1. The American College of Radiology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
5. Physician Credit Designation
   1. The American College of Radiology designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
      
      Each session in this Webinar Series is designated for 1.0 AMA PRA Category 1 Credit™ for a total of 4.0 AMA PRA Category 1 Credits™ for the series.
6. Instructions to Receive Credit
   1. In order to successfully complete the activity, participants must complete an activity evaluation and claim credit commensurate with their participation in the activity.
7. Contact Information
   1. For information about the accreditation of this program, please contact the ACR at info@acr.org.
8. Disclosure of Relevant Financial Relationships
   The ACR Disclosure Policy: The American College of Radiology (ACR) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ACR are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by ACR in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ACR to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ACR.
   
   The following planners and managers have no relevant financial relationships to disclose:
   Aaron Bush, MD; Emile Gogineni DO; Theresa Rudolph, CAPM; Carlye Armstrong, CHCP; Maya Grant
   
   The following planners and managers have the following identified relevant financial relationships:
   Arya Amini, MD - Consulting Fee: AstraZeneca; Contracted Research: Genentech, Varian, ReleXion; Speakers’ Bureau: AstraZeneca, Takeda Pharmaceutical
   
   The following faculty members have no relevant financial relationships to disclose:
   Rachel Jimenez, MD; Jerry J. Jaboin, MD, PhD; Reshma Jagsi, MD, DPhil; Curtiland Deville, Jr., MD
   
    

In this webinar, a diverse panel of expert ACR radiation oncologists will explore themes related to diversity, equity and inclusion, associated challenges and benefits, and framework for solutions to these challenges for diversity & inclusion in the radiation oncology field.

In this webinar, a diverse panel of four expert oncologists focus on leadership perspectives, mentorship, sponsorship, career advice challenges and opportunities in the radiation oncology field.